Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study

Saved in:
Bibliographic Details
Published in:Pragmatic and Observational Research
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552960171048960
collection WordPress RSS
FRELIP Feed Integration
container_title Pragmatic and Observational Research
description
discipline_display Health Facilities and Administration
discipline_facet Health Facilities and Administration
format Online Article
RSS Article
genre Journal Article
id rss_article:69855
institution FRELIP
journal_source_facet Pragmatic and Observational Research
last_indexed 2026-06-20T21:29:20.763Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
Health Facilities and Administration
General
Health Facilities and Administration
sub_discipline_display General
sub_discipline_facet General
subject_display Health Facilities and Administration
General
Health Facilities and Administration
subject_facet Health Facilities and Administration
General
Health Facilities and Administration
title The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
title_alt El impacto potencial de los agonistas del receptor GLP-1 en el riesgo de exacerbación en pacientes con EPOC y diabetes tipo 2: un estudio observacional basado en población real
Impact potentiel des agonistes des récepteurs du GLP-1 sur le risque d'exacerbation chez les patients atteints de BPCO et de diabète de type 2 : une étude observationnelle basée sur la population en conditions réelles
O Impacto Potencial dos Agonistas do Receptor GLP-1 no Risco de Exacerbação em Pacientes com DPOC e Diabetes Tipo 2: Um Estudo Observacional de Base Populacional em Mundo Real
title_auth The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
title_es_txt El impacto potencial de los agonistas del receptor GLP-1 en el riesgo de exacerbación en pacientes con EPOC y diabetes tipo 2: un estudio observacional basado en población real
title_fr_txt Impact potentiel des agonistes des récepteurs du GLP-1 sur le risque d'exacerbation chez les patients atteints de BPCO et de diabète de type 2 : une étude observationnelle basée sur la population en conditions réelles
title_full The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
title_fullStr The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
title_full_unstemmed The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
title_pt_txt O Impacto Potencial dos Agonistas do Receptor GLP-1 no Risco de Exacerbação em Pacientes com DPOC e Diabetes Tipo 2: Um Estudo Observacional de Base Populacional em Mundo Real
title_short The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study
title_sort the potential impact of glp-1 receptor agonists on exacerbation risk in patients with copd and type 2 diabetes: a real-world population-based observational study
topic Health Facilities and Administration
General
Health Facilities and Administration
url https://www.dovepress.com/the-potential-impact-of-glp-1-receptor-agonists-on-exacerbation-risk-i-peer-reviewed-fulltext-article-POR